SCENARIO | Cis-eQTLs | Trans-eQTLs |
---|
S2 | S3 | S4 | S6 | S7 | S8 | S2 | S3 | S4 | S6 | S7 | S8 |
---|
Cis-eQTLs
| S2 | 2,247 | 100% | 57% | 100% | 99% | 59% | 27% | 26% | 0% | 18% | 22% | 0% |
S3 | 2,061 | 2,065 | 56% | 11% | 100% | 58% | 25% | 24% | 0% | 15% | 19% | 0% |
S4 | 1,184 | 1,152 | 2,066 | 5% | 4% | 25% | 13% | 12% | 5% | 4% | 5% | 0% |
S6 | 223 | 219 | 95 | 223 | 95% | 14% | 9% | 10% | 0% | 12% | 16% | 0% |
S7 | 182 | 183 | 81 | 174 | 183 | 13% | 7% | 8% | 0% | 9% | 13% | 0% |
S8 | 361 | 352 | 156 | 88 | 82 | 612 | 2% | 1% | 0% | 2% | 3% | 0% |
Trans-eQTLs
| S2 | 103 | 96 | 50 | 34 | 27 | 7 | 379 | 100% | 60% | 30% | 46% | 69% |
S3 | 76 | 71 | 36 | 29 | 23 | 4 | 291 | 291 | 58% | 7% | 36% | 66% |
S4 | 0 | 0 | 2 | 0 | 0 | 0 | 26 | 25 | 43 | 7% | 32% | 31% |
S6 | 72 | 60 | 18 | 50 | 37 | 9 | 120 | 3 | 93 | 403 | 94% | 14% |
S7 | 58 | 49 | 13 | 41 | 34 | 9 | 121 | 94 | 3 | 249 | 264 | 14% |
S8 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 19 | 9 | 4 | 4 | 29 |
-
eQTLs Expression quantitative trait loci, SNPs Single nucleotide polymorphisms, S2 SNPs from the RNA-seq data of the skeletal muscle, S3 SNPs from the GGP-50K plus the SNPs from the RNA-seq data of the skeletal muscle, S4 SNPs from the GGP-50K plus the SNPs from the RNA-seq data of the skeletal muscle, liver, and brain tissues; S6: SNPs from the RNA-seq data of the skeletal muscle after linkage disequilibrium (LD) pruning; S7: SNPs from the GGP-50K plus the SNPs from the RNA-seq data of the skeletal muscle after LD pruning, and, S8: SNPs from the GGP-50K plus the SNPs from the RNA-seq data of the skeletal muscle, liver, and brain tissues after LD pruning. The table diagonal represents the number of eQTLs identified, the values above the diagonal indicate the percentage of overlapping eQTLs among the scenarios, and the values below the diagonal represent the number of overlapping eQTLs across datasets